CANDRIAM S.C.A. – iTeos Therapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$14.08M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
-7.52%
quarter
iTeos Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.11% | -48.13K shares | -2.13M | $19.05 | 739.51K |
| Q2 2022 | share | Increase | +15.19% | 103.83K shares | -5.77M | $20.6 | 787.65K |
| Q1 2022 | share | Decrease | -9.71% | -73.51K shares | -13.25M | $32.18 | 683.81K |
| Q4 2021 | share | Increase | +44.19% | 232.08K shares | 21.08M | $47.75 | 757.32K |
| Q3 2021 | share | Increase | +4.03% | 20.35K shares | 1.23M | $27 | 525.24K |
| Q2 2021 | share | Increase | +2804844.44% | 504.87K shares | 12.95M | $25.65 | 504.89K |
| Q1 2021 | share | Increase | 0.00% | 18 shares | 1K | $34.18 | 18 |